Aleksander Bilewicz
Warsaw, MZ 03195, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Three Noble Metal Nanoparticles Demonstrated Distinct Biological Interactions and Cell Death Pathways in Human Hepatocarcinoma Cell Lines.
Journal: Nanotechnology, science and applications
Published: January 09, 2026
First positronium lifetime imaging using 52Mn and 55Co with a plastic-scintillator-based PET scanner.
Journal: Scientific reports
Published: December 16, 2025
First ex-vivo positronium imaging of tissues with modular J-PET scanner using 44Sc radionuclide.
Journal: Zeitschrift fur medizinische Physik
Published: October 23, 2025
The radioactive 103Pd and 109Pd palladium bipyridyl-bisphosphonate complexes for radionuclide therapy of bone metastatic tumor cells.
Journal: RSC advances
Published: March 28, 2025
Cytotoxicity Comparison of 99mTc-Labeled Peptide Antagonist and Agonist Targeting the SSTR2 Receptor in AR42J Cells.
Journal: Molecules (Basel, Switzerland)
Published: February 23, 2025
Pt-Au Nanoparticles in Combination with Near-Infrared-Based Hyperthermia Increase the Temperature and Impact on the Viability and Immune Phenotype of Human Hepatocellular Carcinoma Cells.
Journal: International journal of molecular sciences
Published: December 31, 2024
Au@109Pd Core-Shell Nanoparticles Conjugated to Panitumumab for the Combined β--Auger Electron Therapy of Triple-Negative Breast Cancer.
Journal: International journal of molecular sciences
Published: November 18, 2024
109Pd/109mAg in-vivo generator in the form of nanoparticles for combined β- - Auger electron therapy of hepatocellular carcinoma.
Journal: EJNMMI radiopharmacy and chemistry
Published: June 13, 2024
Au@109Pd core-shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers: studies on the applicability of 109Pd/109mAg in vivo generator in combined β- auger electron therapy.
Journal: EJNMMI radiopharmacy and chemistry
Published: September 01, 2023
Improvement of the Effectiveness of HER2+ Cancer Therapy by Use of Doxorubicin and Trastuzumab Modified Radioactive Gold Nanoparticles.
Journal: Molecular pharmaceutics
Published: August 22, 2023
Last Updated: 09/26/2026